Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
601607 On Other Exchanges
Symbol
Exchange
601607 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches and develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. The company operates through Production, Distribution, Retail, and Others segments. It offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, antineoplastic, musculo-skeletal, respiratory, and genito-urinary systems, as well as offers sex hormones and products for blood and blood-forming organs. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It is also involved in the distribution of vaccines and high-end consumables; wholesale of active pharmaceutical ingredients; and provision of distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company operates a network of retail pharmacy stores; manages assets; manufactures and trades medicines and medical equipment; and rents properties. It has approximately 1,895 chain retail pharmacies under its brand family, including 1,193 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

39,891 Employees
Last Reported Date: 03/26/15
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY1.6M
Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Signs Strategic Cooperation Agreement with DXY.cn

Shanghai Pharmaceuticals Holding announced that it has signed a strategic cooperation agreement with DXY.cn. Under terms of the agreement, they will share resources in medical services, big data and drug supply, which will help them build presence both in offline clinics and drug stores. Shanghai Pharmaceuticals's Shanghai Pharmaceuticals Cloud Health will become the exclusive drug supplier of DXY.cn and DXY.cn will offer clinic operation services for Shanghai Pharmaceuticals Cloud Health.

Shanghai Pharmaceuticals Holding Co., Ltd. Presents at UBS Greater China Conference 2016, Jan-11-2016

Shanghai Pharmaceuticals Holding Co., Ltd. Presents at UBS Greater China Conference 2016, Jan-11-2016 . Venue: Pudong Shangri-La Hotel, 33 Fu Cheng Road, Pudong, Shanghai, 200120, China.

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Consolidated and Parent Earnings Results for the Third Quarter and Nine Months Ended September 2015

Shanghai Pharmaceuticals Holding Co., Ltd. announced consolidated and parent earnings results for the third quarter and nine months ended September 2015. For the quarter, on consolidated basis, total revenue was RMB 8,090,262,686.33 against RMB 24,702,971,084.00 a year ago. Operating profit was RMB 894,200,823.80 against RMB 749,575,379.79 a year ago. Net profit was RMB 753,495,444.79 against RMB 699,413,705.33 a year ago. Basic and diluted earnings per share were RMB 0.2398 against RMB 0.2211 a year ago. For the nine months, on consolidated basis, total revenue was RMB 79,040,339,101.51 against RMB 68,715,987,409.43 a year ago. Operating profit was RMB 2,910,110,117.25 against RMB 2,605,904,806.60 a year ago. Net profit was RMB 2,508,260,674.26 against RMB 2,214,054,980.04 a year ago. Basic and diluted earnings per share were RMB 0.8103 against RMB 0.7113 a year ago. Net cash flows from operating activities were RMB 670,197,580.67 against RMB 740,485,653.27 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 1,050,552,482.69 against RMB 651,252,476.74 a year ago. Weighted average return on net assets was 7.63% against 7.21% a year ago. For the quarter, on parent basis, total revenue was RMB 2,584,599.16 against RMB 1,663,329.81 a year ago. Operating profit was RMB 256,022,243.23 against operating loss of RMB 69,144,048.62 a year ago. Net profit was RMB 277,243,125.66 against RMB 41,183,688.98 a year ago. For the nine months, on parent basis, total revenue was RMB 23,801,991.63 against RMB 4,145,276.08 a year ago. Operating profit was RMB 868,526,804.45 against RMB 629,355,606.09 a year ago. Net profit was RMB 906,835,617.50 against RMB 750,179,969.69 a year ago. Net cash flows from operating activities were RMB 116,663,030.88 against net cash used in operating activities was RMB 489,492,581.83 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 32,274,459.14 against RMB 30,197,582.06 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY15.69 CNY +0.13

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY70.59 CNY -0.61
Jointown Pharmaceutical Group Co Ltd CNY17.79 CNY -0.38
Nanjing Pharmaceutical Co Ltd CNY7.37 CNY -0.04
Wanjia Group Holdings Ltd $0.46 HKD -0.045
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 14.3x
Price/Sales 0.4x
Price/Book 1.4x
Price/Cash Flow 10.2x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.